This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Excelmab, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Xuemei Wei - Innovator in Cancer Treatment
Introduction
Xuemei Wei is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies. His work focuses on addressing critical challenges in breast cancer therapy.
Latest Patents
Xuemei Wei holds a patent for a bispecific antibody and its uses, specifically targeting CD3 and tumor antigens such as HER2. This groundbreaking invention provides a method for treating breast cancer, offering new hope for patients. The patent outlines a preparation method and various applications of the antibody, including a composition that utilizes this innovative treatment approach.
Career Highlights
Xuemei Wei is associated with Excelmab, Inc., where he continues to advance his research in antibody development. His dedication to improving cancer therapies has positioned him as a key figure in the biotechnology sector.
Collaborations
Throughout his career, Xuemei Wei has collaborated with notable colleagues, including Wenjun Zhang and Cuijuan Chen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.
Conclusion
Xuemei Wei's contributions to the field of cancer treatment through his innovative bispecific antibody exemplify the impact of dedicated research and collaboration. His work continues to inspire advancements in medical science and offers hope for improved therapies for breast cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile